Fig. 1: LNP-RNA-mediated antigen presentation leverages SARS-CoV-2-specific T-cell immunity to treat tumors.
From: LNP-RNA-mediated antigen presentation leverages SARS-CoV-2-specific immunity for cancer treatment
a Illustration of LNP-RNA-mediated antigen presentation platform. E spike epitope, TM transmembrane domain. Created in BioRender. Xue, Y. (2025) https://BioRender.com/g18v799. b Design and structures of AA lipids. c General synthetic routes of AA lipids.
